Abstract
A comprehensive polymorph and cocrystal study for the natural pharmaceutical molecule scoparone (1) with low solubility was conducted, in which a novel polymorph B and four cocrystals, i.e. scoparone-3,5-difluorobenzoic acid (1a), scoparone-urea (1b), scoparone-pyrimethamine (1c) and scoparone-succinimide (1d), were obtained through solvent crystallization method. The scoparone polymorphs and cocrystals were characterized by powder X-ray diffraction and thermal analysis, the crystal structures of which were determined by single-crystal X-ray diffraction as well. The kinetic dissolution property of polymorphs and cocrystals was conducted in this work. The novel polymorph B is more thermodynamically stable than form A, and exhibits lower maximum dissolution concentration than that of form A. Among the cocrystals, the formation of cocrystal with urea can enhance the drug dissolution concentration compared to form A and form B.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
